🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of rapid British shipping. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting products of unknown origin.

Some experts stated the popularity for retatrutide could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Material Removal

According to TikTok, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The organization said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, populated with photos of slimming results, glowing reviews and step-by-step guides for mixing or administering at home.

Within minutes of entering one group, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.

Item Information and Pricing

Inside these communities, posts show black plastic packages with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to possibly serious health risks”.